Article

Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes

Department of Obstetrics and Gynaecology, McMaster University, Hamilton, Ontario, Canada
Diabetologia (Impact Factor: 6.88). 01/2006; 48(12):2661-6. DOI: 10.1007/s00125-005-0022-5
Source: PubMed

ABSTRACT Epidemiological studies report an increased risk of obesity and type 2 diabetes in children born to women who smoked during pregnancy. This study examines the effect of fetal and neonatal exposure to nicotine, the major addictive component of cigarettes, on postnatal growth, adiposity and glucose homeostasis.
Female Wistar rats were given either saline (vehicle) or nicotine (1 mg kg(-1) day(-1)) during pregnancy and lactation. Serum and pancreas tissue were collected from the infant rats at birth. Postnatal growth was assessed weekly until the rats reached 26 weeks of age and glucose homeostasis was examined by OGTTs performed at 7 and 26 weeks of age.
Exposure to nicotine resulted in increased postnatal growth and adiposity. Nicotine exposure also resulted in dysglycaemia at 7 and 26 weeks of age. Serum insulin concentrations were decreased in the pups exposed to nicotine at birth. This was associated with increased beta cell apoptosis (pups of saline-treated mothers 8.8+/-1.21% apoptotic beta cells; pups of nicotine-treated mothers 27.8+/-3.1% apoptotic beta cells).
Fetal and neonatal exposure to nicotine results in metabolic changes in the offspring that are consistent with obesity and type 2 diabetes. We propose that these metabolic changes may be a consequence of the initial insult to the beta cell during fetal life and that this animal model has many characteristics of diabetes in humans.

0 Followers
 · 
65 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Offspring of smoking mothers during pregnancy have a lower birth weight but have a higher chance to become overweight during childhood. We followed children longitudinally to assess the age when higher BMI z-scores became evident in the children of mothers who smoked during pregnancy, and evaluate the trajectory of changes until adolescence. We pooled data from two German cohort studies that included repeated anthropometric measurements until 14 years and information on smoking during pregnancy and other risk factors for overweight. We used longitudinal quantile regression to estimate age- and sex-specific associations between maternal smoking and the 10(th), 25(th), 50(th), 75(th), and 90(th) quantiles of the BMI z-score distribution in study participants from birth through 14 years of age, adjusted for potential confounders. We used additive mixed models to estimate associations with mean BMI z-scores. Mean and median (50(th) quantile) BMI z-scores at birth were smaller in the children of mothers who smoked during pregnancy compared with children of nonsmoking mothers, but BMI z-scores were significantly associated with maternal smoking beginning at the age of 4-5 years, and differences increased over time. For example, the difference in the median BMI z-score between the daughters of smokers versus nonsmokers was 0.12 (95% CI: 0.01, 0.21) at 5 years, and 0.30 (95% CI: 0.08, 0.39) at 14 years of age. For lower BMI z-score quantiles the association with smoking was more pronounced in girls, whereas in boys the association was more pronounced for higher BMI z-score quantiles. A clear difference in BMI z-score (mean and median) between offspring of smoking and nonsmoking mothers emerged at the age of 4 to 5 years. The shape and size of age-specific effect estimates for maternal smoking during pregnancy varied by age and gender across the BMI z-score distribution.
    Environmental Health Perspectives 04/2014; 122(7). DOI:10.1289/ehp.1307139 · 7.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: While nicotine replacement therapy is assumed to be a safer alternative to smoking during pregnancy, the long-term consequences for the offspring remain elusive. Animal studies now suggest that maternal nicotine exposure during perinatal life leads to a wide range of adverse outcomes for the offspring including increased adiposity. The focus of this study was to investigate if nicotine exposure during pregnancy and lactation leads to alterations in hepatic triglyceride synthesis. Female Wistar rats were randomly assigned to receive daily subcutaneous injections of saline (vehicle) or nicotine bitartrate (1mg/kg/day) for two weeks prior to mating until weaning. At postnatal day 180 (PND180), nicotine exposed offspring exhibited significantly elevated levels of circulating and hepatic triglycerides in the male offspring. This was concomitant with increased expression of fatty acid synthase (FAS), the critical hepatic enzyme in de novo triglyceride synthesis. Given that FAS is regulated by the nuclear receptor Liver X Receptor (LXRα), we measured LXRα expression in both control and nicotine-exposed offspring. Nicotine exposure during pregnancy and lactation led to an increase in hepatic LXRα protein expression and enriched binding to the putative LXRE element on the FAS promoter in PND180 male offspring. This was also associated with significantly enhanced acetylation of histone H3 [K9,14] surrounding the FAS promoter, a hallmark of chromatin activation. Collectively, these findings suggest that nicotine exposure during pregnancy and lactation leads to an increase in circulating and hepatic triglycerides long-term via changes in the transcriptional and epigenetic regulation of the hepatic lipogenic pathway.
    Toxicology and Applied Pharmacology 12/2013; DOI:10.1016/j.taap.2013.12.010 · 3.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Some studies reported similar effect estimates for the impact of maternal smoking in pregnancy and paternal smoking on childhood obesity, whereas others suggested higher effects for maternal smoking. We performed a meta-analysis to compare the effect of in utero exposure to maternal smoking and that of paternal or household smoking exposure in utero or after birth with mutual adjustment. Methods: Meta-analysis of observational studies identified in MEDLINE, EMBASE and Web of Knowledge published in 1900-2013. Study inclusion criterion was assessment of the association of maternal smoking during pregnancy and paternal or household smoking (anyone living in the household who smokes) at any time with childhood overweight and obesity. The analyses were based on all studies with mutually adjusted effect estimates for maternal and paternal/household smoking applying a random-effects model. Results: Data for 109 838 mother/child pairs were reported in 12 studies. The pooled odds ratios (ORs) for overweight 1.33 [95% confidence interval (CI) 1.23; 1.44] (n = 6, I-2 = 0.00%) and obesity 1.60 (95% CI 1.37; 1.88) (n = 4, I-2 = 32.47%) for maternal smoking during pregnancy were higher than for paternal smoking: 1.07 (95% CI 1.00; 1.16) (n = 6, I-2 = 41.34%) and 1.23 (95% CI 1.10; 1.38) (n = 4, I-2 = 14.61%), respectively. Similar estimates with widely overlapping confidence limits were found for maternal smoking during pregnancy and childhood overweight and obesity: 1.35 (95% CI 1.20; 1.51) (n = 3, I-2 = 0.00%) and 1.28 (95% CI 1.07; 1.54) (n = 3, I-2 = 0.00%) compared with household smoking 1.22 (95% CI 1.06; 1.39) (n = 3, I-2 = 72.14%) and 1.31 (95% CI 1.15; 1.50)] (n = 3, I-2 = 0.00%). Conclusions: Higher effect estimates for maternal smoking in pregnancy compared with paternal smoking in mutually adjusted models may suggest a direct intrauterine effect.
    International Journal of Epidemiology 07/2014; 43(5). DOI:10.1093/ije/dyu150 · 9.20 Impact Factor

Full-text (2 Sources)

Download
36 Downloads
Available from
May 23, 2014